By This GLP Editorial Team · Updated October 2026Royal Medical Center review
Royal Medical Center describes a compounded GLP-1 weight-loss program with laboratory assessment, individualized dosing and follow-up. Confirm the precise medication and pharmacy.
The verdict
Royal’s useful promise is an integrated clinical program rather than an isolated refill. Laboratory review, adjustments and continuing consultations are explicitly listed. The remaining work is to turn a broad compounded-GLP-1 offer into a named prescription, a practical follow-up schedule and a clearly identified dispensing pharmacy.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The practice offers hormone and weight-management services for men and women. Its weight-loss page is titled for tirzepatide and describes compounded GLP-1 injections. That heading is relevant, but the actual prescribed ingredient and concentration still need to appear on the patient’s order.
Who writes the prescription, and what do they see?
The service describes doctor-guided care and a comprehensive medical evaluation. A prescriber determines medical necessity. Ask which clinician would conduct the consultation and manage later dose changes; a general practice description does not assign a particular professional.
The listed program includes health evaluation, laboratory testing, consultations, progress monitoring and lifestyle support. These are useful categories, but the frequency and contact method are not fully specified. Establish whether follow-ups are booked visits, messages or both.
What happens when the dose goes up?
Royal describes customized dosing and adjustments according to response. It does not establish one public milligram schedule for every patient. Ask how side effects are assessed, what a delayed refill means for the course and which monitoring is needed before the next prescription.
What the price includes
The treatment page publishes an entry monthly figure and says medication, supplies, physician consultations, follow-ups and lab monitoring are included. Confirm which prescription and supply duration qualify and whether a higher dose changes the bill. A general starting figure is not a complete dose ladder.
What it claims, and what it cites
The offer is described as compounded treatment. Such preparations are not FDA-approved, and trial evidence for approved products does not establish the same performance for a specific compounded vial. Obtain the pharmacy identity, formulation and storage instructions before choosing the program.
Where it holds up, and where it does not
- Strength: Assessment and monitoring are listed together
- Strength: Supplies and follow-up appear in the package
- Strength: Dose decisions are individualized
- Limitation: Public follow-up frequency is incomplete
- Limitation: Precise prescription and pharmacy need confirmation
- Limitation: Starting price does not establish all dose costs
What the evidence says about this kind of treatment
The assessment above is about Royal Medical Center. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone seeking a broader physician-guided weight-management program who can clarify the prescription and continuing-care arrangements.
- Wrong for
- A patient needing an approved branded product or a complete public clinical and dose-price schedule.
The evidence behind what Royal Medical Center prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Royal Medical Center compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: Obu HealthOmnia TeleHealthOmzoOndra HealthRaelivaOnlyRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Is the service simply a pharmacy order?
- The page describes evaluation, labs, consultations and monitoring in addition to medication.
- Is a particular dose guaranteed?
- No. The program describes customized dosing subject to the prescriber’s clinical decision.
- Are compounded injections FDA-approved?
- No. A compounded preparation is not an FDA-approved finished product.
Sources for this review
Provider information checked . Terms can change.